Our ground-breaking technologies and research results are available for partnering and commercialisation.
The following projects can be accessed through UWA's Research Development and Innovation office:
Cement Reduced, High Early Strength Shotcrete
A new technology, that independent of the mix components not only increases shotcrete’s strength and workability, but also results in significant cost savings.
Herbicides with novel modes of action
UWA researchers are using cross-disciplinary approaches in chemical biology, synthetic organic chemistry and classical genetics to discover plant processes and plant proteins that can be targets for new herbicides.
Inspired by the results ofscreening antimalarial and other drug libraries plus knowledge of antimalarial drug action, they are putting new modesof action ‘on the table’.
Methods of controlling mineral slurry rheology and improving ore purity
The University of Western Australia’s (UWA) Professor Yee-Kwong Leong has developed economic methods of controlling the viscosities of mineral ore slurries to facilitate their transportation and/or storage. In addition, Professor Leong has developed a method of triggering the separation of mineral slurries into their constituent layers to facilitate recovery of valuable minerals or improve ore purity prior to further separation.
Flash flaming of seeds to improve land restoration
UWA researchers have developed a device that carefully heats seeds to remove the fluffy appendages that make many seeds difficult to store, transport, coat and handle. The device will have an impact in large scale land revegetation projects, such as minesite restoration.
Improved Efficiency MED Evaporation / Liquid Stream Concentration
Using waste heat sources from 65-90oC, this technology improves the efficiency of Multiple Effect Distillation/Evaporation processes, increasing freshwater production by 30 to 55% while simultaneously reducing heat rejection loads to evaporation towers or ponds.
Arginine-rich neuroprotective peptides
UWA researchers have discovered intrinsic neuroprotective properties of arginine-rich peptides, presenting the possibility of a new class of neuroprotective molecules for the treatment of a range of neurological disorders, including stroke.
Triple negative breast cancer therapy
UWA researchers have developed a compound that selectively decreases chemoresistance in triple negative tumours providing a new therapeutic opportunity for these cancer patients.
Interfacial Toughening of composites with ultra-thin Kevlar® layer
The weakest link of adhesive joints, or between layers of composite materials, is typically a thin layer of e.g. epoxy resin. Adding an ultra-thin layer of aramid fibres to this thin resin layer in question can significantly improve the performance of the joint / composite component. Protruding free fibre ends of the short Kevlar fibres connect/bridge the interface and thus improve adhesion.
A platform for identifying new synergistic drug-immunotherapy combinations
A network analysis approach for identifying novel IO-drug combinations, based on the study of gene expression signatures in immunotherapy-induced progressing or regressing tumours.
Novel Zeolite Adsorbents for separation of Methane and Nitrogen
A novel Zeolite-based adsorbent for separation of methane and nitrogen with a selectivity of 6-8 - outperforming all known industrial adsorbents in its ability to separate methane from nitrogen and it is well suited for Swing Adsorption methods (such as Pressure Swing Adsorption and Vacuum Swing Adsorption).
Tumour targeted LIGHT (TNFSF14) therapy
UWA researchers have developed a novel targeted-cytokine drug, LIGHT-RGR, which is shown to promote tumour vasculature normalization, and to enhance tumour perfusion and infiltration of activated immune cells. LIGHT-RGR has significant potential in checkpoint immunotherapy-combination approaches, and also as an adjunct to enhance trafficking and infiltration of engineered T cells (CAR-T cell therapies) into solid tumours.
High-Performance Dual Reflux Swing Adsorption System
Researchers at UWA have developed a novel design methodology for Dual Reflux Pressure Swing Adsorption (DR-PSA) systems that leads directly to the optimum design for a set of given inputs with excellent correlation between simulation and implementation thus eliminating costly and time consuming trial & error.
A novel matrix-targeted anti-cancer drug
UWA researchers have developed a novel targeted-TNF anti-cancer therapy which causes highly selective degradation of tumour-extra cellular matrix (ECM). In models of liver, breast and pancreatic cancer this drug is shown to reduce ECM content, tumour stiffness and interstitial pressure, and to increase tumour perfusion.
This targeted-TNF also has anti-tumorigenic monotherapeutic effects, however unlike native TNF, this drug does not cause systemic toxicity.
High-Intensity Magnetic Field Focusing Cavity
Researchers at UWA have developed a Multi-post 3D Split Ring Re-entrant Cavity Lattice as a hybrid platform for integration of quantum systems – suitable for multi-frequency sensing, probing of magnetic and dielectric properties of solids (spectroscopy) and many other "quantum" applications.
